Revolution Medicines, Inc.
Close on Nov 20, 2026Market cap $34.55BP/E –Yield –
Revolution Medicines 2033 Convertible Senior Notes by Quarter
2033 Convertible Senior Notes — Carrying value (net of unamortized issuance costs) ($M) ($M)
Revolution Medicines 2033 Convertible Senior Notes: $488M in Q3 2026, up 180,596.3% from a year earlier.
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-11-04) ↗
Reported in Form 10-Q / 10-K Consolidated Balance Sheets & Debt Note.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2033 Convertible Senior Notes — Carrying value (net of unamortized issuance costs) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 488 | +180,596.3% | Form 10-Q (filed 2026-11-04) ↗ |
| Q2 2026 | Jun 30, 2026 | 487 | – | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 0.24 | – | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 0 | – | Form 10-Q (filed 2026-11-04) ↗ |
| Q3 2025 | Sep 30, 2025 | 0.27 | – | Form 10-Q (filed 2025-11-05) ↗ |
Cite this data
StockData. (2026). Revolution Medicines 2033 Convertible Senior Notes ($M), quarterly Q3 2025–Q3 2026 [Data set]. Compiled from Revolution Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/rvmd/kpis/conv-notes-carrying
See every metric in the Revolution Medicines KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?